Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report

Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report

Introduction: Hepatocellular carcinoma (HCC) is by far the leading malignant indication for liver transplantation (LT). Few other malignancies, including cholangiocellular carcinoma (CCC), metastases from neuroendocrine tumors (NET), and sarcomas of the liver (LSAR), also are commonly accepted indic...

Full description

Bibliographic Details
Main Authors: Philipp Houben, Simon Schimmack, Christian Unterrainer, Bernd Döhler, Arianeb Mehrabi, Caner Süsal
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Surgery
Subjects:
liver transplantation
transplant oncology
hepatocellular carcinoma
cholangiocellular carcinoma
neuroendocrine tumor
liver sarcoma liver transplantation for rare malignancies
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2021.678392/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2021.678392/full

Similar Items